Argent Trust Co Has $13.41 Million Holdings in Colgate-Palmolive Company (NYSE:CL)

Argent Trust Co lessened its holdings in Colgate-Palmolive Company (NYSE:CL) by 0.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 143,074 shares of the company’s stock after selling 1,055 shares during the period. Argent Trust Co’s holdings in Colgate-Palmolive were worth $13,406,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Deutsche Bank AG raised its holdings in shares of Colgate-Palmolive by 35.6% in the 4th quarter. Deutsche Bank AG now owns 6,922,994 shares of the company’s stock worth $629,369,000 after acquiring an additional 1,816,865 shares during the last quarter. Diamond Hill Capital Management Inc. raised its holdings in shares of Colgate-Palmolive by 45.0% in the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock worth $521,250,000 after acquiring an additional 1,727,105 shares during the last quarter. Castlekeep Investment Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter worth about $111,738,000. Renaissance Technologies LLC raised its holdings in shares of Colgate-Palmolive by 70.2% in the 4th quarter. Renaissance Technologies LLC now owns 2,808,110 shares of the company’s stock worth $255,285,000 after acquiring an additional 1,158,060 shares during the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Colgate-Palmolive by 10,601.7% in the 1st quarter. GAMMA Investing LLC now owns 1,105,379 shares of the company’s stock worth $103,574,000 after acquiring an additional 1,095,050 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.4%

Shares of CL stock opened at $83.51 on Friday. The company has a 50 day moving average of $89.59 and a 200-day moving average of $90.30. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. Colgate-Palmolive Company has a 12-month low of $82.70 and a 12-month high of $109.30. The firm has a market cap of $67.68 billion, a P/E ratio of 23.46, a PEG ratio of 4.31 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter last year, the business posted $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 1.0% compared to the same quarter last year. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date is Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.76%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CL shares. Wall Street Zen lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $103.00 to $99.00 and set an “overweight” rating for the company in a research note on Friday, July 25th. Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a “buy” rating in a research note on Monday, April 28th. Barclays increased their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 15th. Finally, UBS Group decreased their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $100.58.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.